2022 annual financial data
Vir Biotechnology 2022 Net margin
Direct answer
Net margin was 31.92%.
Operating income was 833,068,000 USD and net income was 515,837,000 USD.
Operating cash flow was 1,663,253,000 USD.
Get free Vir Biotechnology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,615,797,000 USD
- Operating income
- 833,068,000 USD
- Net income
- 515,837,000 USD
- Operating cash flow
- 1,663,253,000 USD